Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Feb;65(2):711-8.
doi: 10.1128/JVI.65.2.711-718.1991.

Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1

Affiliations

Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1

C Leclerc et al. J Virol. 1991 Feb.

Abstract

Proliferative T-cell responses to poliovirus in various strains of mice have been analyzed by using either killed purified virus or capsid protein VP1 synthetic peptides. Following immunization of mice with inactivated poliovirus type 1 (PV1), a specific proliferative response of their lymph node CD4+ T cells was obtained after in vitro stimulation with purified virus. In mice immunized with PV1, PV2, or PV3, a strong cross-reactivity of the T-cell responses was observed after in vitro stimulation with heterologous viruses. By using various strategies, a dominant T-cell epitope was identified in the amino acid 103 to 115 region of capsid polypeptide VP1, close by the C3 neutralization epitope. The T-cell response to VP1 amino acids 103 to 115 is H-2 restricted: H-2d mice are responders, whereas H-2k and H-2b mice do not respond to this T-cell epitope. Immunization of BALB/c (H-2d) mice with the uncoupled p86-115 peptide, which represents VP1 amino acids 86 to 115 and contains both the T-cell epitope and the C3 neutralization epitope, induced poliovirus-specific B- and T-cell responses. Moreover, these mice developed poliovirus neutralizing antibodies.

PubMed Disclaimer

References

    1. J Immunol. 1983 Nov;131(5):2445-51 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Feb;82(3):910-4 - PubMed
    1. Immunology. 1987 May;61(1):1-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1610-4 - PubMed
    1. Science. 1988 Jul 8;241(4862):213-5 - PubMed

Publication types

MeSH terms